ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,708.60
3.40 (0.20%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.40 0.20% 1,708.60 1,708.60 1,708.80 1,713.00 1,699.40 1,701.60 11,522,668 16:29:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.27 70.34B

GlaxoSmithKline PLC Director/PDMR Shareholding (7719C)

19/04/2017 4:14pm

UK Regulatory


Gsk (LSE:GSK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Gsk Charts.

TIDMGSK

RNS Number : 7719C

GlaxoSmithKline PLC

19 April 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Mr B McNamara 
===  ========================  =============================================== 
 b)   Position/status          CEO, GSK Consumer Healthcare 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           American Depositary Shares ('ADSs') 
       the financial            I 
       instrument               SIN: US37733W1053 
===  ========================  =============================================== 
 b)   Nature of the            Increase in notional interest in ADSs following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 13 April 2017 on ADSs held 
                                in the Company's 2009 Performance Share 
                                Plan. 
===  ========================  =============================================== 
 c)   Price(s) and              Price(s)   Volume(s) 
       volume(s)                ---------  ---------- 
                                 $41.81     90.871 
                                ---------  ---------- 
                                 $41.81     454.207 
                                ---------  ---------- 
                                 $41.81     701.005 
                                ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information 
       Aggregated volume 
        Price 
 
                                1,246.083 
                                 $41.81 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-04-18 
===  ========================  =============================================== 
 f)   Place of the             n/a 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Mr D E Troy 
===  ========================  =============================================== 
 b)   Position/status          SVP & General Counsel 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           American Depositary Shares ('ADSs') 
       the financial            ISIN: US37733W1053 
       instrument 
===  ========================  =============================================== 
 b)   Nature of the            Increase in notional interest in ADSs following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 13 April 2017 on ADSs held 
                                in the Company's 2009 Performance Share 
                                Plan. 
===  ========================  =============================================== 
 c)   Price(s) and              Price(s)   Volume(s) 
       volume(s)                ---------  ---------- 
                                 $41.81     1,237.606 
                                ---------  ---------- 
                                 $41.81     1,435.850 
                                ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information 
       Aggregated volume 
        Price 
 
                                2,673.456 
                                 $41.81 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-04-18 
===  ========================  =============================================== 
 f)   Place of the             n/a 
       transaction 
===  ========================  =============================================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEKLFFDZFFBBB

(END) Dow Jones Newswires

April 19, 2017 11:14 ET (15:14 GMT)

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock